The Evolving Treatment Landscape of Metastatic Gastric and Gastroesophageal Junction Cancers

home / insights / the-evolving-treatment-landscape-of-metastatic-gastric-and-gastroesophageal-junction-cancers

Key thought leaders in gastrointestinal oncology build a lively discussion on recent clinical trial updates on immuno-oncology-based combinations for the management of patients with metastatic gastric and gastroesophageal junction cancers and the implications for clinical practice.